S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

GILD Gilead Sciences Inc

89.76

1.13 (1.27%)

After Hours

Last Updated: 08:00:10

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Gilead Sciences Charts.

Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Gilead Sciences Charts.

Gilead Sciences Inc News

Form 8-K - Current report
Thursday 21 November 2024 (24 hours ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 16 November 2024 (6 days ago) • Edgar (US Regulatory)

Gilead’s Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis
Saturday 16 November 2024 (6 days ago) • Business Wire

Gilead Prices $3.5 Billion of Senior Unsecured Notes
Thursday 14 November 2024 (1 week ago) • Business Wire

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 14 November 2024 (1 week ago) • Edgar (US Regulatory)

Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
Wednesday 13 November 2024 (1 week ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (1 week ago) • Edgar (US Regulatory)

Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline
Tuesday 12 November 2024 (1 week ago) • Business Wire

Gilead Sciences to Present at Upcoming Investor Engagements
Saturday 9 November 2024 (2 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (2 weeks ago) • Edgar (US Regulatory)

More Gilead Sciences Inc News Articles

Newcrest Mining

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions